Literature DB >> 6260693

Cyclic AMP-mediated modulation of the production of the second component of human complement by monocytes.

D Lappin, K Whaley.   

Abstract

The production of the second complement component (C2) by human monocytes in culture was inhibited by increasing their intracellular concentrations of cAMP following the addition to the culture medium of dibutyryl-cyclic AMP, 8-bromo-cyclic AMP, theophylline, isobutylmethylxanthine, cholera toxin or adenosine. The effects were not due to cytotoxicity or loss of cells from the monolayers, and therefore must reflect a decreased synthesis of section of C2. Although dibutyryl-cyclic GMP enhanced C2 production, 8-bromo-cyclic GMP, ascorbic acid and sodium nitroprusside did not have this effect. These observations suggest that the action of dibutyryl-cyclic GMP is not due to elevation of cyclic GMP levels and that cyclic GMP levels do not play a major role in C2 production by monocytes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6260693     DOI: 10.1159/000232742

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  10 in total

1.  Adrenergic receptors on monocytes modulate complement component synthesis.

Authors:  D Lappin; K Whaley
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

Review 2.  Complement biosynthesis by mononuclear phagocytes.

Authors:  A R McPhaden; K Whaley
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

3.  Anaphylatoxins inhibit C2 production.

Authors:  D Lappin; B Damerau; K Whaley
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

4.  Adenosine A2 receptors on human monocytes modulate C2 production.

Authors:  D Lappin; K Whaley
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

5.  Cyclic nucleotides and their relationship to complement-component-C2 synthesis by human monocytes.

Authors:  D Lappin; D W Riches; B Damerau; K Whaley
Journal:  Biochem J       Date:  1984-09-01       Impact factor: 3.857

6.  Role of C3 in the control of monocyte C2 production.

Authors:  A O Hamilton; L Morrison; W S Kilpatrick; D Lappin; J C Bensa; D W Riches; K Whaley
Journal:  Immunology       Date:  1984-01       Impact factor: 7.397

7.  Prostaglandins and prostaglandin synthetase inhibitors regulate the synthesis of complement components by human monocytes.

Authors:  D F Lappin; K Whaley
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

8.  Modulation of mRNA expression and secretion of C1q in mouse macrophages by anti-inflammatory drugs and cAMP: evidence for the partial involvement of a pathway that includes cyclooxygenase, prostaglandin E2 and adenylate cyclase.

Authors:  P K Trinder; D Faust; F Petry; M Loos
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

9.  Control of monocyte C2 production by cyclic AMP.

Authors:  D Lappin; K Whaley
Journal:  Immunology       Date:  1983-08       Impact factor: 7.397

Review 10.  Purinergic signalling and immune cells.

Authors:  Geoffrey Burnstock; Jean-Marie Boeynaems
Journal:  Purinergic Signal       Date:  2014-10-29       Impact factor: 3.765

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.